Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-67856633 |
Trade Name | |
Synonyms | JNJ67856633|JNJ 67856633 |
Drug Descriptions |
JNJ-67856633 is an inhibitor that blocks the activity of mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), resulting in decreased NF-kappaB and JAK/STAT signaling, potentially leading to increased apoptosis and decreased growth of MALT1-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C160147 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ibrutinib + JNJ-67856633 | Ibrutinib JNJ-67856633 | 0 | 1 |
JNJ-64264681 + JNJ-67856633 | JNJ-64264681 JNJ-67856633 | 0 | 1 |
JNJ-67856633 | JNJ-67856633 | 0 | 1 |